← FDA DRUG APPROVALS

FDA NDA · NDA017553

PROGESTASERT

Sponsor: ALZA

APPLICATION
NDA017553
TYPE
NDA
ORIGINAL APPROVAL
1976-02-04
LATEST ACTION
1998-01-28
ROUTE
INTRAUTERINE
DOSAGE FORM
INSERT, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PROGESTASERTDiscontinued
PROGESTERONE 38MG · INSERT, EXTENDED RELEASE · INTRAUTERINE

Approval history

1998-01-28Manufacturing (CMC) · Supplement 29 · priorityAP
1995-02-03Labeling · Supplement 27 · priorityAP
1994-05-27Manufacturing (CMC) · Supplement 28 · priorityAP
1993-08-05Manufacturing (CMC) · Supplement 26 · priorityAP
1990-07-03Manufacturing (CMC) · Supplement 25 · priorityAP
1989-07-13Labeling · Supplement 24 · priorityAP
1988-03-03Manufacturing (CMC) · Supplement 23 · priorityAP
1987-05-19Labeling · Supplement 22 · priorityAP
1979-05-30Manufacturing (CMC) · Supplement 10 · priorityAP
1979-05-30Manufacturing (CMC) · Supplement 9 · priorityAP
1977-04-08Manufacturing (CMC) · Supplement 3 · priorityAP
1976-05-03Manufacturing (CMC) · Supplement 1 · priorityAP
1976-02-04Type 3 - New Dosage Form · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →